Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christian Hugo

Showing results (91-100 of 131) with videos related to

Pageof 14
Sort By:
Kidney International|March 15, 2013
The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patientsHanna Trydzenskaya, Karsten Juerchott, Nils Lachmann, et al.
Kidney International|September 12, 2021
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponseTimm H Westhoff, Felix S Seibert, Moritz Anft, et al.
Transplantation|May 14, 2010
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trialMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Journal of Nephrology|July 6, 2021
Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patientsMoritz Anft, Arturo Blazquez-Navarro, Ulrik Stervbo, et al.
Journal of Nephrology|December 2, 2022
Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivationArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Frontiers in Transplantation|July 12, 2024
High incidence and viral load of HHV-6A in a multi-centre kidney transplant cohortArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Kidney International Reports|June 15, 2026
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension StatusRicardo Correa-Rotter, Peter Rossing, Maria Eugenia Canziani, et al.
Scientific Reports|November 12, 2020
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantationSharon Bajda, Arturo Blazquez-Navarro, Björn Samans, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup AnalysesDavid Z I Cherney, Peter Rossing, Maria Eugenia Canziani, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosisAlexia Belavgeni, Stefan R Bornstein, Anne von Mässenhausen, et al.
Pageof 14

Showing results (91-100 of 131) with videos related to

Sort By:
Pageof 14
Kidney International|March 15, 2013
The genetic predisposition of natural killer cell to BK virus-associated nephropathy in renal transplant patientsHanna Trydzenskaya, Karsten Juerchott, Nils Lachmann, et al.
Kidney International|September 12, 2021
A third vaccine dose substantially improves humoral and cellular SARS-CoV-2 immunity in renal transplant recipients with primary humoral nonresponseTimm H Westhoff, Felix S Seibert, Moritz Anft, et al.
Transplantation|May 14, 2010
Renal function, efficacy, and safety of sirolimus and mycophenolate mofetil after short-term calcineurin inhibitor-based quadruple therapy in de novo renal transplant patients: one-year analysis of a randomized multicenter trialMarkus Guba, Johann Pratschke, Christian Hugo, et al.
Journal of Nephrology|July 6, 2021
Detection of pre-existing SARS-CoV-2-reactive T cells in unexposed renal transplant patientsMoritz Anft, Arturo Blazquez-Navarro, Ulrik Stervbo, et al.
Journal of Nephrology|December 2, 2022
Lack of predictive capacity of pre-transplant anti-BK virus antibodies for post-transplant reactivationArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Frontiers in Transplantation|July 12, 2024
High incidence and viral load of HHV-6A in a multi-centre kidney transplant cohortArturo Blazquez-Navarro, Toralf Roch, Patrizia Wehler, et al.
Kidney International Reports|June 15, 2026
Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension StatusRicardo Correa-Rotter, Peter Rossing, Maria Eugenia Canziani, et al.
Scientific Reports|November 12, 2020
The role of soluble mediators in the clinical course of EBV infection and B cell homeostasis after kidney transplantationSharon Bajda, Arturo Blazquez-Navarro, Björn Samans, et al.
Diabetes, Obesity & Metabolism|May 5, 2026
Effects of Vicadrostat/Empagliflozin in People With Chronic Kidney Disease: Metabolic Subgroup AnalysesDavid Z I Cherney, Peter Rossing, Maria Eugenia Canziani, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 16, 2019
Exquisite sensitivity of adrenocortical carcinomas to induction of ferroptosisAlexia Belavgeni, Stefan R Bornstein, Anne von Mässenhausen, et al.
Pageof 14